Oranda Therapeutics is a rare disease company, focused on acquiring, developing and commercialising  medicines that improve the lives of patients in areas of high unmet need.  We have a portfolio of established rare disease medicines and are building a scalable, best in class rare disease commercialisation platform

Our team has extensive BioPharma expertise, specifically in late-stage development, product licensing, commercialisation (having led over 20 successful European rare disease medicine launches), and lean organisational build out.

Oranda Therapeutics is seeking to further in-license and acquire rare disease medicines in late-stage clinical development.  We are flexible, transparent and committed to forging creative deals and long term collaborations.

Oranda Therapeutics

Org chart

Teams

Offices